alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
----

Corrigendum to the Commission Directive 2004/93/EC of 21 September 2004 amending Council Directive 76/768/EEC for the purpose of adapting its Annexes II and III to technical progress

(Official Journal of the European Union L 300 of 25 September 2004)

On page 24, reference 663:

for:

               ‘(2RS,3RS)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)-[1H-1,2,4-triazol-1-yl)methyl]oxirane (CAS No 106325-08-0)’,

read:

               ‘(2RS,3RS)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)-[1H-1,2,4-triazol-1-yl)methyl]oxirane (CAS No 133855-98-8)’;

on page 40, reference 1107:

for:

               ‘Solvent yellow 14 (CAS No 842-07-9)’,

read:

               ‘C.I Solvent yellow 14 (CAS No 842-07-9)’;

on page 41, reference 1127:

for:

               ‘Mineral wool, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate)fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O + K2O + CaO + MgO + BaO) content greater than 18 % by weight] (EC No 406-230-1)’,

read:

               ‘Mineral wool, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate)fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O + K2O + CaO + MgO + BaO) content greater than 18 % by weight]’;

reference 1128:

for:

               ‘Reaction product of acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid’,

read:

               ‘Reaction product of acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid (EC No 406-230-1)’;

reference 1131:

for:

               ‘Trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulfonato-1-naphtholato)chromate(1-)’,

read:

               ‘Trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulfonato-1-naphtholato)chromate(1-) (EC No 400-810-8)’;

reference 1132:

for:

               ‘A mixture of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol, 4-allyl-6-(3-(6-(3-(6-(3-(4-allyl-2,6-bis(2,3-epoxypropyl)-phenoxy)2-hydroxypropyl)-4-allyl-2-(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl)-4-allyl-2-(2,3-epoxypropyl)-phenoxy-2-hydroxypropyl-2-(2,3-epoxypropyl)phenol, 4-allyl-6-(3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl)-2-(2,3-epoxypropyl)phenoxy)phenol and 4-allyl-6-(3-(6-(3-(4-allyl-2,6-bis(2,3-epoxypropyl)-phenoxy)-2-hydroxypropyl)-4-allyl-2-(2,3-epoxypropyl)phenoxy)2-hydroxypropyl)-2-(2,3-epoxypropyl)phenol’            

read:

               ‘A mixture of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol, 4-allyl-6-(3-(6-(3-(6-(3-(4-allyl-2,6-bis(2,3-epoxypropyl)-phenoxy)2-hydroxypropyl)-4-allyl-2-(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl)-4-allyl-2-(2,3-epoxypropyl)-phenoxy-2-hydroxypropyl-2-(2,3-epoxypropyl)phenol, 4-allyl-6-(3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2- hydroxypropyl)-2-(2,3-epoxypropyl)phenoxy)phenol and 4-allyl-6-(3-(6-(3-(4-allyl-2,6-bis(2,3-epoxypropyl)-phenoxy)-2-hydroxypropyl)-4-allyl-2-(2,3-epoxypropyl)phenoxy)2-hydroxypropyl)-2-(2,3-epoxypropyl)phenol (EC No 417-470-1)’.

----
----

            COMMISSION REGULATION (EC) No 543/2005

of 8 April 2005         

establishing the standard import values for determining the entry price of certain fruit and vegetables

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Commission Regulation (EC) No 3223/94 of 21 December 1994 on detailed rules for the application of the import arrangements for fruit and vegetables (1), and in particular Article 4(1) thereof,

Whereas:

HAS ADOPTED THIS REGULATION:

Article 1

The standard import values referred to in Article 4 of Regulation (EC) No 3223/94 shall be fixed as indicated in the Annex hereto.

Article 2

This Regulation shall enter into force on 9 April 2005.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 8 April 2005.

For the Commission

J. M. SILVA RODRÍGUEZ            

Director-General for Agriculture and Rural Development

----

(1)OJ L 337, 24.12.1994, p. 66. Regulation as last amended by Regulation (EC) No 1947/2002 (OJ L 299, 1.11.2002, p. 17).

----

ANNEX

to Commission Regulation of 8 April 2005 establishing the standard import values for determining the entry price of certain fruit and vegetables

----

(1)  Country nomenclature as fixed by Commission Regulation (EC) No 2081/2003 (OJ L 313, 28.11.2003, p. 11). Code ‘            999            ’ stands for ‘of other origin’.

----
§ 62.3 Who is eligible to apply for a scholarship program award? ( a ) To be eligible for a scholarship under this part an applicant must: ( 1 ) Be accepted for enrollment, or be enrolled, as a full-time student in a school located in a State;
( 2 ) Be pursuing a course of study or program offered by the school leading to a degree in medicine, osteopathy, dentistry, or an equivalent credential for a particular health profession;
( 3 ) Be eligible for, or hold, an appointment as a commissioned officer in the Regular or Reserve Corps of the Service or be eligible for selection for civilian service in the National Health Service Corps;
( 4 ) Be a National of the United States; and
( 5 ) Submit an application to participate in the Scholarship Program together with a signed contract as described in section 751(f) of the Act.
( b ) Any applicant who owes an obligation for professional practice to a State or other entity under an agreement entered into before filing an application under this part is ineligible for an award unless a written statement satisfactory to the Secretary is submitted from the State or entity that ( 1 ) there is no potential conflict in fulfilling the service obligation to the State or entity and the Scholarship Program, and that
( 2 ) the Scholarship Program service obligation will be served before the service obligation for professional practice owed to the State or entity.
( c ) Any individual who receives a scholarship under the Indian Health Service Scholarship Program (section 757 of the Act) or the Scholarship Program for First-Year Students of Exceptional Financial Need (section 758 of the Act) is ineligible to participate in the Scholarship Program during the School year(s) for which the scholarships under sections 757 or 758 of the Act were awarded.
§ 600.305 Eligible individuals. ( a ) *Eligibility standards* The State must determine individuals eligible to enroll in a standard health plan if they: ( 1 ) Are residents of the State.
( 2 ) Have household income which exceeds 133 percent but does not exceed 200 percent of the FPL for the applicable family size, or, in the case of an individual who is a lawfully present non-citizen, ineligible for Medicaid or CHIP due to such immigration status, whose household income is between zero and 200 percent of the FPL for the applicable family size.
( 3 ) Are not eligible to enroll in minimum essential coverage (other than a standard health plan). If an individual meets all other eligibility standards, and— ( i ) Is eligible for, or enrolled in, coverage that does not meet the definition of minimum essential coverage, including Medicaid that is not minimum essential coverage, the individual is eligible to enroll in a standard health plan without regard to eligibility or enrollment in Medicaid; or
( ii ) Is eligible for Employer Sponsored Insurance (ESI) that is unaffordable (as determined under section 36B(c)(2)(C) of the Internal Revenue Code), the individual is eligible to enroll in a standard health plan.
( 4 ) Are 64 years of age or younger.
( 5 ) Are either a citizen or lawfully present non-citizen.
( 6 ) Are not incarcerated, other than during a period pending disposition of charges.
( b ) *Eligibility restrictions.* With the exception of during an approved implementation period specified in a transition plan in accordance with § 600.145, the State may not impose conditions of eligibility other than those identified in this section, including, but not limited to, restrictions on eligibility based on geographic location or imposition of an enrollment cap or a waiting period for individuals previously eligible for or enrolled in other coverage.
###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.

#### § 7.5 [Reserved]
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.165 Plant drawings.

(a) Plant patent drawings should be artistically and competently executed and must comply with the requirements of § 1.84. View numbers and reference characters need not be employed unless required by the examiner. The drawing must disclose all the distinctive characteristics of the plant capable of visual representation.

(b) The drawings may be in color. The drawing must be in color if color is a distinguishing characteristic of the new variety. Two copies of color drawings or photographs must be submitted.

[58 FR 38726, July 20, 1993, as amended at 65 FR 57058, Sept. 20, 2000; 69 FR 56543, Sept. 21, 2004]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER

Appellate case name: In the Interest of Z. T., a minor child

Appellate case number: 01-13-00407-CV

Trial court case number: 2012-32356

Trial court: 312th District Court of Harris County

This is an appeal of a termination decree. The notice of appeal does not indicate that 

appellant is presumed indigent, and therefore appellant is required to pay the filing fee and to pay 

for the record in this appeal. The record in this appeal was due on May 25, 2013. The district 

clerk and the court reporter have informed this Court that the appellant has neither requested nor 

paid for either record in this appeal. Because this is a termination case, the Court is required to 

bring this appeal to final disposition within 180 days of the date the notice of appeal was filed so 

far as reasonably possible. See Tex. R. Jud. Admin. 6.2, reprinted in TEX. GOV’T CODE ANN., 

tit. 2, subtit. F app. (West Supp. 2012). 

Accordingly, appellant is hereby ORDERED to file proof that appellant has requested 

and paid for or made arrangements to pay for the clerk’s record in this appeal within 5 days of 

the date of this order. If proof that appellant has paid for or made arrangements to pay for the 

clerk’s record is not filed within 5 days of the date of this order, this appeal may be dismissed for 

want of prosecution without further notice. See TEX. R. APP. P. 37.3(b).

Appellant is further ORDERED to file proof that appellant has requested and paid for or 

made arrangements to pay for the reporter’s record in this appeal within 5 days of the date of 

this order. If proof that appellant has paid for or made arrangements to pay for the reporter’s 

record is not filed within 5 days of the date of this order, the Court may consider and decide 

those issues or points that do not require a reporter’s record for a decision. See TEX. R. APP. P.

37.3(c).

It is so ORDERED.

Judge’s signature: /s/ Evelyn V. Keyes

 Acting individually  Acting for the Court

Date: ___May 30, 2013___________________
§ 493.1283 Standard: Test records. ( a ) The laboratory must maintain an information or record system that includes the following: ( 1 ) The positive identification of the specimen.
( 2 ) The date and time of specimen receipt into the laboratory.
( 3 ) The condition and disposition of specimens that do not meet the laboratory's criteria for specimen acceptability.
( 4 ) The records and dates of all specimen testing, including the identity of the personnel who performed the test(s).
( b ) Records of patient testing including, if applicable, instrument printouts, must be retained.
§ 70.11 Report of death or illness onboard aircraft operated by an airline. ( a ) The pilot in command of an aircraft operated by an airline who is conducting a commercial passenger flight in interstate traffic under a regular schedule shall report as soon as practicable to the Director the occurrence onboard of any deaths or the presence of ill persons among passengers or crew and take such measures as the Director may direct to prevent the potential spread of the communicable disease, provided that such measures do not affect the airworthiness of the aircraft or the safety of flight operations.
( b ) The pilot in command of an aircraft operated by an airline who reports in accordance with paragraph (a) of this section shall be deemed to satisfy the reporting obligation under 42 CFR 70.4.
[82 FR 6971, Jan. 19, 2017]
###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Part 2

#### Editorial Note:

Nomenclature changes to part 2 appear at 68 FR 14337, Mar. 25, 2003.

#### § 2.54 Requirements for drawings submitted on paper.

The drawing must meet the requirements of § 2.52. In addition, in a paper submission, the drawing should:

(a) Be on non-shiny white paper that is separate from the application;

(b) Be on paper that is 8 to 8.5 inches (20.3 to 21.6 cm.) wide and 11 to 11.69 inches (27.9 to 29.7 cm.) long. One of the shorter sides of the sheet should be regarded as its top edge. The image must be no larger than 3.15 inches (8 cm) high by 3.15 inches (8 cm) wide;

(c) Include the caption “DRAWING PAGE” at the top of the drawing beginning one inch (2.5 cm.) from the top edge; and

(d) Depict the mark in black ink, or in color if color is claimed as a feature of the mark.

(e) Drawings must be typed or made with a pen or by a process that will provide high definition when copied. A photolithographic, printer's proof copy, or other high quality reproduction of the mark may be used. All lines must be clean, sharp and solid, and must not be fine or crowded.

[68 FR 55764, Sept. 26, 2003]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
Exhibit 31(b)
 CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)
  1.
    
    I have reviewed this report on Form 10-Q of Interphase Corporation (the Company);
 2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
 3.
    
    Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the Company as of, and for, the periods presented in this report;
 4.
    
    The Companys other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the Company and have:
     5.
    
    The Companys other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the Companys auditors and the
audit committee of the Companys board of directors:
   Date: November 3, 2010
    Signature:
    /s/ Thomas N. Tipton Jr.Chief Financial Officer
exv10w20



 



EXHIBIT 10.20



January 10, 2002


Chris Fedde

125 Theodora Ct.

Forest Hill, MD 21050


Dear Chris:


Confirming our discussions, I am pleased to offer you a promotion beginning on
January 1, 2002, as Vice President, Enterprise Security Products, which reports
directly to me. In this role, you will be responsible for the direction of the
products and the management of the employees in the Enterprise Products
Division for SafeNet.


Your compensation will be increased to an annual base salary of $155,000 (paid
at $5,961.54 on a bi-weekly basis), subject to all State and Federal
withholdings. You will also be eligible for a 50% or ($77,500) annual bonus
based on the achievement of the Enterprise Product Division Operating Income
goals and on SafeNet, Inc. eps targets for the year.


SafeNet is granting, subject to final approval by our Board of Directors, an
additional option to purchase 15,000 shares of SafeNet stock under the
Company’s 2001 Omnibus Stock Option Plan. These shares shall vest over a
period of 4 years at 25% per year. An official Stock Option Agreement will be
forwarded to you shortly after you accept this position.


You will also continue to be eligible to participate in any benefit program
offered or adopted by the Company.


Employment with SafeNet, Inc is considered an employment-at-will relationship.
Although we hope your employment with SafeNet will be long term, either you or
SafeNet may terminate the relationship, at any time, with or without cause or
notice.


If the foregoing confirms our understanding, please sign and return the
enclosed copy of this letter. I am looking forward to working with you in this
new role and hope that your employment relationship with SafeNet will continue
to be a rewarding and positive experience.


Sincerely,


/s/ Anthony A. Caputo


Anthony A. Caputo

President and Chief Executive Officer


I accept and agree to the terms and conditions of employment as set forth in
this letter.



	 	 	 	 	 	 	 
	SIGNED:	 	
/s/ Chris Fedde
	 	DATED:
	 	January 11, 2002






 







 



	 	 	 
	Date:	 	
April 25, 2002
	 	 	 
	To:	 	
Chris Fedde
	 	 	
Vice President, Enterprise Products
	 	 	 
	From:	 	
Anthony A. Caputo
	 	 	
President and CEO
	 	 	 
	Re:	 	
Addendum to Offer Letter dated January 10, 2002













Dear Chris,


Confirming our discussions, this Addendum states that:


In the event of Company-initiated Termination without cause, you will be
entitled to receive 6 months of severance payments computed by using the latest
applicable salary rate.


In the event of a termination for cause, you are not eligible to receive any
severance payments.


Your signature at the bottom of this document will constitute an acceptance of
this Addendum and it’s terms.


Sincerely,


/s/ Anthony A. Caputo


Anthony A. Caputo

President and CEO



	 	 	 
	/s/ Chris Fedde	 	
April 26, 2002
	
	 	


	Chris Fedde	 	
Date
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AND STATEMENT OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                           1,500
<SECURITIES>                                        48
<RECEIVABLES>                                    1,395
<ALLOWANCES>                                     (220)
<INVENTORY>                                      6,763
<CURRENT-ASSETS>                                10,671
<PP&E>                                           8,934
<DEPRECIATION>                                 (7,953)
<TOTAL-ASSETS>                                  23,632
<CURRENT-LIABILITIES>                           21,971
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       100,079
<OTHER-SE>                                       3,000
<TOTAL-LIABILITY-AND-EQUITY>                    23,632
<SALES>                                          5,426
<TOTAL-REVENUES>                                 5,853
<CGS>                                            3,903
<TOTAL-COSTS>                                    4,268
<OTHER-EXPENSES>                                 6,364
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 529
<INCOME-PRETAX>                                (5,452)
<INCOME-TAX>                                        41
<INCOME-CONTINUING>                            (5,493)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,493)
<EPS-BASIC>                                      (.06)
<EPS-DILUTED>                                    (.06)


</TABLE>